BioMarck Pharmaceuticals, Ltd. Announces A New Patent On The Use Of…

Research Triangle Park, North Carolina based BioMarck Pharmaceuticals was granted a United States Patent No. 8,293,870 for its proprietary peptide BIO-11006 for the treatment of Chronic Obstructive…

(PRWeb November 14, 2012)

Read the full story at

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.